The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths forward.
Other content in this Stream
Spectrum News - St. Joe's - Cardio Genetics Testing
According to the cdc, heart disease is the leading cause of death in America. Going all the way back to the 1950's. and while people have become familiar with genetic testing for cancer risk.
Providence study finds AI ambient listening tool modestly reduces documentation burden, improves provider efficiency
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
Providence to participate in federally funded research for early detection of a behavioral health crisis
Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.
Providence receives esteemed NIH grant for ‘paradigm shift’ in head and neck cancer treatments
Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.
New Providence study identifies provider-patient relationships as central to colorectal cancer screening disparities
A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.
New Prevention4ME Study: Access Matters More Than Outreach in Genetic Screening
Findings suggest that while outreach yields low engagement, low-cost methods such as email are feasible, and point-of-care access is critical for improving participation and equity. Health systems sho
Scaling insights into immunotherapy with GigaTIME
Researchers from Providence, the University of Washington, and Microsoft developed GigaTIME, a publicly available AI model that generates spatial proteomic images at scale.
Providence rolls out toolkit to boost cancer research equity
A research team from Renton, Wash based Providence has launched an interactive toolkit to help health systems boost equity in medical research.
Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations
Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients
Trust gap a key driver of underrepresentation of racially and ethnically diverse communities in medical research, Providence study reveals
Researchers develop framework for health systems to build bridges and engage Black, Latino and American Indian communities in medical research
New Study: Why this breakthrough in pig-to-human kidney research matters
A new Providence-led study published in Nature offers one of the most detailed looks yet at what actually happens inside the body after a pig kidney is transplanted into a human.
New Providence study identifies key risk factors for early-onset colorectal Cancer
A Cross-Sectional Retrospective Case-Control Study on Predictors of Early Onset Colorectal Cancer in a Multi-State Community Health System.
Novel AI framework anticipated to unlock tumor secrets, lead to new treatments
Providence, Microsoft Research, University of Washington unveil GigaTIME, an AI-powered pathology breakthrough set to transform cancer immunotherapy research
Celebrating the launch of RESOLVE: A Rural Health Collaborative
Over 100 leaders, researchers and others from Montana and the Pacific Northwest recently convened for the announcement of a pioneering rural health collaborative from Providence and the University of
Geno4ME Study Show How Whole Genome Sequencing May Impact Routine Genetic Screening
Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible
Whole Genome Sequencing Poised to Transform Routine Genetic Screening
Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible.
Understanding the Progression of Ductal Carcinoma in Situ (DCIS) to Invasive Breast Cancer (IBC)
This study includes authors from Providence Genomics in collaboration with Providence Swedish Cancer Institute.